Samsung gets FDA clearance for irregular heart notification feature, catching up with Apple and Fitbit

Samsung has received clearance from the U.S. Food and Drug Administration for an irregular heart rhythm notification feature for its Galaxy Watch devices to passively monitor wearers for signs of atrial fibrillation (Afib).